INDIA TURNS DOWN ELI LILLY'S PATENT PLEA (for its biotechnology …Therapeutics Daily (subscription) (press release), PA - 5 hours agoThe patent office in Kolkata has rejected the patent application of Eli Lilly Company (ELC) of the US for its biotechnology based Forteo, …
Read full story
European Commission Approves New Storage Instructions for BYETTA(R)PR Newswire UK (press release), UK - 7 hours ago"We are pleased with the approval of the updated label in Europe," said James Malone, MD, global medical director at Eli Lilly and Company. …
Read full story
Eli Lilly says study shows LY2140023 compound improves …CNNMoney.com - Sep 4, 20074, 2007 (Thomson Financial delivered by Newstex) — Eli Lilly (NYSE:LLY) & Co said a trial of its LY2140023 investigational compound has shown …Study: New Drug mGlu2/3 Has Antipsychotic Activity in Humans Associated ContentNew Schizophrenia Drug Shows Promise WebMDEli Lilly opens door for next-generation antipsychotics OutSourcing-Pharma.comall 10 news articles
Read full story
Inside INdiana Business (press release)Conner Prairie to Honor Founder Eli LillyInside INdiana Business (press release), IN - 23 hours agoThis year, Conner Prairie will honor a single person–its founder, Eli Lilly and his innovating vision and legacy by showcasing the museum with an elegant …
Read full story
Examining Drugs for 'adhd'PR-GB.com (press release), Bulgaria - 11 hours agoThe Eli Lilly company has been marketing a new drug for those who are labeled as ADHD known as Strattera. This drug is purported to be a non-stimulant …
Read full story
Lilly's Pipeline Continues to ProduceMotley Fool - 23 hours agoAnother winner has been Eli Lilly (NYSE: LLY), returning 9%. This company's strength is in its pipeline, and shareholders heard more good news from its …Foolish Fantasy Football: 3 Drug Companies Motley Foolall 2 news articles
Read full story
Nicholas's NCE pipeline at Rs 1000-1300 cr: EmkayEconomic Times, India - Sep 4, 2007Nicholas Piramal has also entered into research collaboration with ELI Lilly for a metabolic compound, to conduct late pre-clinical Phase-I and Phase-II …Buy Nicholas Piramal with target Rs 326: Sharekhan Moneycontrol.comBuy Nicholas Piramal; target of Rs 395: Citigroup Moneycontrol.comall 7 news articlesEli Lilly and Co - Google News
Read full story
Eli Lilly & Co Data Affirm Benefit Of AlimtaCNNMoney.com - 3 hours agoThe study results affirm important efficacy and safety benefits for Eli Lilly and Company's ALIMTA, the only-known agent to demonstrate a survival benefit …Eli Lilly says benefits of lung cancer drug Alimta affirmed in … ForbesLilly Cancer Drug Works in Japanese, Taiwanese Trials (Update3) BloombergPharmacyclics Announces Encouraging Phase 2 Data With Xcytrin(R … CNNMoney.comall 11 news articles
Read full story
Ontario NowHopeful newsSan Diego CityBEAT, CA - 11 hours agoWe can only hope that the settlement money Eli Lilly has had to pay out to Zyprexa users—$1.2 billion and counting—will force company officials to think …Eli Lilly seeking a better Zyprexa Indianapolis StarEli Lilly says study shows LY2140023 compound improves … CNNMoney.comStudy: New Drug mGlu2/3 Has Antipsychotic Activity in Humans Associated ContentWebMD - Bloombergall 91 news articles
Read full story
Londonderry drug firm admits to selling fake CialisEagle Tribune, MA - 3 hours agoThe tablets were identical to prescription Cialis tablets made by Indiana-based Eli Lilly and Co. to treat erectile dysfunction, according to an affidavit …
Read full story
Pharmaceutical Group Paid Lobbyist $100KForbes, NY - 1 hour agoThe trade group, whose members include Amgen Inc., Eli Lilly & Co. and Pfizer Inc., lobbied on patent reform, according to the form posted online Aug. …Nisource Spent $220000 Lobbying in 2007 Forbesall 10 news articles
Read full story
Lilly's top man leaves to start his own businessZiarul Financiar, Romania - 19 hours agoMarius Savu, the general manager of the domestic unit of US drug maker Eli Lilly, intends to relinquish his position at the company and start his own …
Read full story
Kyle Krisiloff, No. 14, Lilly/Walgreens, CA RecapAutochannel (press release) - Sep 4, 2007It¹ll be another opportunity for the Lilly/Walgreens Ford to get another top-15 finish.² Eli Lilly and Company, a leading innovation-driven corporation, …
Read full story
Trade commission wins lawsuit against US pharmaceutical companyKorea.net, South Korea - Sep 3, 2007At that time, the trade body said it could not find any conclusive evidence that Eli Lilly and Company's patents were being violated by Indian drug company …
Read full story
Eli Lilly Says Metabotropic Glutamate 2/3 Receptors Demonstrates …RTT News, NY - Sep 2, 20079/2/2007 1:12:00 PM Eli Lilly & Co. (LLY) on Sunday said a phase II study published in the scientific journal Nature Medicine demonstrated that for the …
Read full story
Earthtimes.orgEli Lilly seeking a better ZyprexaIndianapolis Star, United States - 9 hours agoBy John Russell Eli Lilly and Co. is testing a new drug for schizophrenia that it says works quickly and safely without resulting in weight gain, …Trial shows hope for schizophrenia drug–Lilly ReutersLilly's Schizophrenia Drug Targets Different Brain Chemicals BloombergNew schizophrenia drug shows promise in trials International Herald TribuneCNNMoney.com - DrugResearcher.comall 70 news articles
Read full story
Business incentives in state top $400MIndianapolis Star, United States - Sep 1, 2007Those benefiting from the incentives included drug giant Eli Lilly and Co., Kroger grocery stores and Kite Realty, a national developer overhauling Glendale …
Read full story
Putting retirees' expertise to workLos Angeles Times, CA - 14 hours agoStarted in 2003 with early support from Procter & Gamble Co., Eli Lilly & Co. and Boeing Co., YourEncore has expanded to a network of more than 22 companies …
Read full story
Employee exodusIndianapolis Star, United States - 10 hours agoAnd Eli Lilly and Co. offers flextime and on-site child care. At eTapestry, loyalty is one of the top priorities, said Jay Love, president. …
Read full story
Lilly and Takeda to Terminate Joint Development/Co-Marketing …PharmaLive.com (press release), PA - Aug 30, 2007Inhibitor, LY333531) in Japan, between Eli Lilly and Company (“Eli Lilly”), which is a parent company of Eli Lilly Japan, and Takeda was terminated. …
Read full story